Barriers for Deriving Transgene‐Free Pig iPS Cells with Episomal Vectors

E-ISSN： 1549-4918|33|11|3228-3238

ISSN： 1066-5099

Source： STEM CELLS, Vol.33, Iss.11, 2015-11, pp. : 3228-3238

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HPGCD Outperforms HPBCD as a Potential Treatment for Niemann‐Pick Disease Type C During Disease Modeling with iPS Cells

STEM CELLS, Vol. 33, Iss. 4, 2015-04 ,pp. : 1075-1088

John Wiley & Sons Inc

Access to resources Recommend Favorite

Loss of ADAR1 in human iPS cells promotes caspase3‐mediated apoptotic cell death

GENES TO CELLS, Vol. 20, Iss. 8, 2015-08 ,pp. : 675-680

John Wiley & Sons Inc

Access to resources Recommend Favorite

New Protocol to Optimize iPS Cells for Genome Analysis of Fibrodysplasia Ossificans Progressiva

STEM CELLS, Vol. 33, Iss. 6, 2015-06 ,pp. : 1730-1742

John Wiley & Sons Inc

Access to resources Recommend Favorite

Generation of GFAP::GFP astrocyte reporter lines from human adult fibroblast‐derived iPS cells using zinc‐finger nuclease technology

GLIA, Vol. 64, Iss. 1, 2016-01 ,pp. : 63-75

John Wiley & Sons Inc

Access to resources Recommend Favorite

Corrigendum: HPGCD Outperforms HPBCD as a Potential Treatment for Niemann‐Pick Disease Type C During Disease Modeling with iPS Cells

STEM CELLS, Vol. 33, Iss. 9, 2015-09 ,pp. : 2885-2886

John Wiley & Sons Inc

Access to resources Recommend Favorite